mcl
Showing NaN - NaN of 1
MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)
Recruiting
- MCL
- Mantle Cell Lymphoma
- Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
-
Odense, Denmark
- +21 more
Feb 11, 2022